News about Global Pharma

Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene

Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.

Global Pharma | 21/05/2024 | By Aishwarya |  999

Biocon Biologics Gets FDA Approval for Biosimilar Aflibercept for Yesafili

Biocon Biologics Ltd (BBL) has announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili.

Global Pharma | 21/05/2024 | By Aishwarya |  549

Astellas Pharma and YASKAWA Sign MOU to Explore Innovative Cell Therapy Ecosystem

Astellas will contribute cell manufacturing technology, clinical development, and regulatory insights related to cell therapy, while YASKAWA will provide and develop robotics and factory automation technologies.

Global Pharma | 21/05/2024 | By Abha |  619

YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE

The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.

Global Pharma | 21/05/2024 | By Abha |  646

Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer

Dr. Marlowe joins Chroma from Solid Biosciences (previously AvantiBio), where she was the Chief Scientific Officer, leading discovery, research, and translational development.

Global Pharma | 20/05/2024 | By Manvi |  709

Shoulder Innovations Introduces InSet 95 Humeral Stem

This product is designed to enhance surgical outcomes and improve patient recovery for those suffering from poor bone quality.

Global Pharma | 20/05/2024 | By Manvi |  555

GC Biopharma and Novel Pharma Sanfilippo Syndrome Treatment Receives FDA IND Approval

GC Biopharma and Novel Pharma has announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.

Global Pharma | 20/05/2024 | By Aishwarya |  804

Cresilon Announces Distribution Agreement for VETIGEL in the UK and Europe

VETIGEL, a plant-based hemostatic gel designed to instantly stop and control bleeding, will be available online through Vi’s extensive range of surgical and orthopedic instruments.

Global Pharma | 20/05/2024 | By Abha |  693

Vector Laboratories and Absolute Biotech Announce Merger to Enhance Life Sciences Offerings

This strategic move aims to solidify Vector Laboratories' position as a comprehensive supplier of custom-engineered and catalog antibodies, sophisticated bioconjugation linkers, and expertise in bioconjugation.

Global Pharma | 20/05/2024 | By Abha |  1051

Jagsonpal Pharmaceuticals to Acquire India and Bhutan Business of Yash Pharma

Jagsonpal Pharmaceuticals Ltd. has signed a Business Transfer Agreement for the acquisition of India and Bhutan business of Yash Pharma for INR 92.47 Crores.

Global Pharma | 20/05/2024 | By Aishwarya |  1446